Literature DB >> 22987817

Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.

David I Pryor1, Sandro V Porceddu, Paul A Scuffham, Jennifer A Whitty, Paul A Thomas, Bryan H Burmeister.   

Abstract

BACKGROUND: The aim of this economic analysis was to model different strategies using pre-treatment nodal stage or nodal response assessment with CT or positron emission tomography (PET)/CT to determine the need for neck dissection.
METHODS: A cost-minimization analysis was developed on the basis of probability data from a prospective study of PET-guided management of the neck in patients achieving a complete response at the primary site. Costs were derived from our institution's activity-based clinical costing system. The effect of uncertainty was tested with sensitivity and scenario analyses including nationally representative cost data.
RESULTS: Strategies incorporating PET had a 7% rate for neck dissection compared with 44% for CT-guided and 90% for planned neck dissection. The cost per patient was A$16,502 for planned neck dissection, A$8014 for CT-guided, and A$2573 for PET-guided. A policy with PET used only for incomplete response on CT was the least-cost strategy (A$2111). Policies incorporating PET remained the most efficient for all sensitivity/scenario analyses.
CONCLUSION: The incorporation of PET/CT into nodal response assessment significantly reduced the number of unnecessary neck dissections and generated considerable cost savings in our cohort.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  PET; cost; head and neck; radiotherapy; response

Mesh:

Substances:

Year:  2012        PMID: 22987817     DOI: 10.1002/hed.23108

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

Review 1.  Defining value-driven care in head and neck oncology.

Authors:  Benjamin R Roman; Mahmoud I Awad; Snehal G Patel
Journal:  Curr Oncol Rep       Date:  2015-01       Impact factor: 5.075

2.  Value-based Healthcare: Applying Time-driven Activity-based Costing in Orthopaedics.

Authors:  Aakash Keswani; Nicole Sheikholeslami; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2018-12       Impact factor: 4.176

3.  Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Matthew E Spector; Matthew H Stenmark; Carol R Bradford; Gregory T Wolf; Francis P Worden; Douglas B Chepeha; Jonathan B McHugh; Thomas Carey; Ka Kit Wong; Avraham Eisbruch
Journal:  Oral Oncol       Date:  2013-12-31       Impact factor: 5.337

4.  Adding MR Diffusion Imaging and T2 Signal Intensity to Neck Imaging Reporting and Data System Categories 2 and 3 in Primary Sites of Postsurgical Oral Cavity Carcinoma Provides Incremental Diagnostic Value.

Authors:  A Jajodia; G Mandal; V Yadav; J Khoda; J Goyal; S Pasricha; S Puri; A Dewan
Journal:  AJNR Am J Neuroradiol       Date:  2022-06-23       Impact factor: 4.966

Review 5.  The economic burden of head and neck cancer: a systematic literature review.

Authors:  Erika Wissinger; Ingolf Griebsch; Juliane Lungershausen; Talia Foster; Chris L Pashos
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.